Clinical Trials
3 trialsNCT01096992 2019-09-25
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01088984 2016-05-23
Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1/2 Completed
NCT00790855 2012-12-04
Bendamustine in Acute Leukemia and MDS
M.D. Anderson Cancer Center
Phase 1/2 Terminated